Industry News, Trustworthy Insights

Popular Companies:

Pfizer’s BioNTech buys UK AI start-up InstaDeep in £562m deal

In its largest-ever transaction, BioNTech has agreed to purchase UK artificial intelligence start-up InstaDeep for up to £562 million as the German business diversifies beyond the Covid-19 vaccine that has completely changed its fortunes.

Biontech founders Uğur Şahin, Özlem Türeci, the married couple who developed the Pfizer vaccine

The biotech startup is attempting to use machine learning to accelerate the drug development process and provide customised therapies based on a patient’s cancer. The agreement followed a lengthy partnership with London-based InstaDeep that produced an early warning system to foretell new Sars CoV-2 virus strains. Last year, BioNTech contributed to InstaDeep’s £100 million investment round.

Using “computational solutions,” according to BioNTech’s chief executive Uur Ahin, the German pharmaceutical company has concentrated on developing customised medications known as immunotherapies since its founding.With the purchase of InstaDeep, he added, “we are now able to integrate the fast

Industry news used by professionals

Try £4.99 per month

Already a member?
Weekly Digest

All the week’s industry events straight to your inbox.

Before your sign up, please read terms of use and privacy policy.

Trending

FREE Weekly Newsletter

Trusted industry insights used by Professionals

By signing up you agree to our terms of use and privacy policy.

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Password Reset

You will soon receive a Reset Password link

FREE Weekly Newsletter

Trusted industry insights used by Professionals

By signing up you agree to terms of use and privacy policy.

Send us your article

[formidable id=3]